BioMaxima S.A. (BMX.WA)
PLN 11.7
(-2.5%)
PLN 11.7
(-2.5%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 586 Thousand PLN | -97.97% |
| 2022 | 28.88 Million PLN | 182.0% |
| 2021 | 10.24 Million PLN | 28.86% |
| 2020 | 7.94 Million PLN | 56686.68% |
| 2019 | 13.99 Thousand PLN | 102.9% |
| 2018 | -481.98 Thousand PLN | -159.82% |
| 2017 | 805.68 Thousand PLN | -34.38% |
| 2016 | 1.22 Million PLN | -15.61% |
| 2015 | 1.45 Million PLN | 219.84% |
| 2014 | 454.83 Thousand PLN | -65.55% |
| 2013 | 1.32 Million PLN | -3.98% |
| 2012 | 1.37 Million PLN | 37.65% |
| 2011 | 998.95 Thousand PLN | 85.32% |
| 2010 | 539.04 Thousand PLN | -11.69% |
| 2009 | 610.36 Thousand PLN | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 250 Thousand PLN | 168.82% |
| 2024 Q2 | -431 Thousand PLN | -272.4% |
| 2023 Q3 | -366 Thousand PLN | -195.31% |
| 2023 FY | 586 Thousand PLN | -97.97% |
| 2023 Q1 | 475 Thousand PLN | 51.27% |
| 2023 Q2 | 384 Thousand PLN | -19.16% |
| 2023 Q4 | 93 Thousand PLN | 125.41% |
| 2022 FY | 28.88 Million PLN | 182.0% |
| 2022 Q1 | 24.19 Million PLN | 1112.73% |
| 2022 Q2 | 3.44 Million PLN | -85.77% |
| 2022 Q3 | 933 Thousand PLN | -72.91% |
| 2022 Q4 | 314 Thousand PLN | -66.35% |
| 2021 Q4 | 1.99 Million PLN | 48.0% |
| 2021 Q1 | 6.26 Million PLN | 108.38% |
| 2021 Q2 | 639 Thousand PLN | -89.79% |
| 2021 FY | 10.24 Million PLN | 28.86% |
| 2021 Q3 | 1.34 Million PLN | 110.95% |
| 2020 Q4 | 3 Million PLN | 151.23% |
| 2020 Q2 | 3.06 Million PLN | 999.97% |
| 2020 Q1 | 278.28 Thousand PLN | -17.89% |
| 2020 FY | 7.94 Million PLN | 56686.68% |
| 2020 Q3 | 1.19 Million PLN | -60.93% |
| 2019 FY | 13.99 Thousand PLN | 102.9% |
| 2019 Q1 | -176.5 Thousand PLN | 73.36% |
| 2019 Q2 | -117.96 Thousand PLN | 33.17% |
| 2019 Q3 | -57.97 Thousand PLN | 50.85% |
| 2019 Q4 | 338.92 Thousand PLN | 684.64% |
| 2018 Q2 | 514.01 Thousand PLN | 105.11% |
| 2018 FY | -481.98 Thousand PLN | -159.82% |
| 2018 Q1 | 250.6 Thousand PLN | 1079.1% |
| 2018 Q3 | -584.06 Thousand PLN | -213.63% |
| 2018 Q4 | -662.53 Thousand PLN | -13.43% |
| 2017 FY | 805.68 Thousand PLN | -34.38% |
| 2017 Q2 | 115.12 Thousand PLN | -63.65% |
| 2017 Q1 | 316.69 Thousand PLN | -21.01% |
| 2017 Q4 | 21.25 Thousand PLN | -94.54% |
| 2017 Q3 | 389.02 Thousand PLN | 237.93% |
| 2016 Q1 | 444.31 Thousand PLN | 6.68% |
| 2016 Q4 | 400.94 Thousand PLN | 115.95% |
| 2016 Q3 | 185.66 Thousand PLN | -5.65% |
| 2016 Q2 | 196.79 Thousand PLN | -55.71% |
| 2016 FY | 1.22 Million PLN | -15.61% |
| 2015 Q2 | 319.81 Thousand PLN | -22.63% |
| 2015 FY | 1.45 Million PLN | 219.84% |
| 2015 Q1 | 413.37 Thousand PLN | 162.13% |
| 2015 Q4 | 416.51 Thousand PLN | 36.54% |
| 2015 Q3 | 305.04 Thousand PLN | -4.62% |
| 2014 Q3 | -169.55 Thousand PLN | -208.97% |
| 2014 Q2 | 155.59 Thousand PLN | -49.99% |
| 2014 Q1 | 311.09 Thousand PLN | 35.48% |
| 2014 Q4 | 157.69 Thousand PLN | 193.01% |
| 2014 FY | 454.83 Thousand PLN | -65.55% |
| 2013 Q3 | 435.65 Thousand PLN | 26.78% |
| 2013 Q4 | 229.62 Thousand PLN | -47.29% |
| 2013 FY | 1.32 Million PLN | -3.98% |
| 2013 Q1 | 311.46 Thousand PLN | -69.93% |
| 2013 Q2 | 343.62 Thousand PLN | 10.33% |
| 2012 Q1 | 211.06 Thousand PLN | 0.0% |
| 2012 FY | 1.37 Million PLN | 37.65% |
| 2012 Q2 | 72.96 Thousand PLN | -65.43% |
| 2012 Q4 | 1.03 Million PLN | 1771.26% |
| 2012 Q3 | 55.34 Thousand PLN | -24.15% |
| 2011 FY | 998.95 Thousand PLN | 85.32% |
| 2010 FY | 539.04 Thousand PLN | -11.69% |
| 2009 FY | 610.36 Thousand PLN | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Scope Fluidics S.A. | -18.78 Million PLN | 103.12% |
| Selvita S.A. | 69.87 Million PLN | 99.161% |
| Voxel S.A. | 74.2 Million PLN | 99.21% |